UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Extracorporeal photopheresis: cellular therapy for the treatment of acute and chronic graft-versus-host disease

Hematology, 2017-12, Vol.2017 (1), p.639-644

Schneiderman, Jennifer

2017

Volltextzugriff (PDF)

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Journal of clinical apheresis, 2019-06, Vol.34 (3), p.171-354

2019

Volltextzugriff (PDF)

Late Effects in Pediatric High-risk Neuroblastoma Survivors After Intensive Induction Chemotherapy Followed by Myeloablative Consolidation Chemotherapy and Triple Autologous Stem Cell Transplants

Journal of pediatric hematology/oncology, 2018-01, Vol.40 (1), p.31-35

2018

Volltextzugriff (PDF)

Pre-transplant infusion of donor leukocytes treated with extracorporeal photochemotherapy induces immune hypo-responsiveness and long-term allograft survival in murine models

Scientific reports, 2022-05, Vol.12 (1), p.7298-7298, Article 7298

2022

Volltextzugriff (PDF)

Non-pharmacologic strategies in hematopoietic stem cell transplantation

Current pharmaceutical design, 2008-07, Vol.14 (20), p.1987-1996

Schneiderman, Jennifer

2008

Volltextzugriff (PDF)

SP-19 - Update on extracorporeal photopheresis (ECP)

Leukemia research, 2019-10, Vol.85, p.S10-S10

Schneiderman, Jennifer

2019

Volltextzugriff (PDF)

Update on extracorporeal photopheresis (ECP)

Leukemia research, 2019-10, Vol.85, p.S10

Schneiderman, Jennifer

2019

Volltextzugriff (PDF)

Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma

Pediatric blood & cancer, 2014-08, Vol.61 (8), p.1350-1356

2014

Volltextzugriff (PDF)

Clinical Significance of MYCN Amplification and Ploidy in Favorable-Stage Neuroblastoma: A Report From the Children's Oncology Group

Journal of clinical oncology, 2008-02, Vol.26 (6), p.913-918

2008

Volltextzugriff (PDF)

The Impact of High-resolution HLA-A, HLA-B, HLA-C, and HLA-DRB1 on Transplant-related Outcomes in Single-unit Umbilical Cord Blood Transplantation in Pediatric Patients

Journal of pediatric hematology/oncology, 2017-01, Vol.39 (1), p.26-32

2017

Volltextzugriff (PDF)

American council on ECP (ACE): Why now?

Journal of clinical apheresis, 2018-08, Vol.33 (4), p.464-468

2018

Volltextzugriff (PDF)

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue

Journal of clinical apheresis, 2023-04, Vol.38 (2), p.77-278

2023

Volltextzugriff (PDF)

Betibeglogene Autotemcel Gene Therapy for Non–β0/β0 Genotype β-Thalassemia

The New England journal of medicine, 2022-02, Vol.386 (5), p.415-427

2022

Volltextzugriff (PDF)

Allogeneic hematopoetic stem cell transplantation in pediatric myelodysplastic syndromes: Improved outcomes for de novo disease

Pediatric transplantation, 2011-05, Vol.15 (3), p.334-343

2011

Volltextzugriff (PDF)

Extracorporeal photopheresis in pediatric patients: Practical and technical considerations

Journal of clinical apheresis, 2017-12, Vol.32 (6), p.543-552

2017

Volltextzugriff (PDF)

A Novel Mutation in WAS Gene Causing a Phenotypic Presentation of Wiskott-Aldrich Syndrome: A Case Report

Journal of pediatric hematology/oncology, 2021-03, Vol.43 (2), p.e234-e236

2021

Volltextzugriff (PDF)

Reduced‐toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high‐risk hematologic malignancies

Pediatric blood & cancer, 2021-08, Vol.68 (8), p.e29087-n/a

2021

Volltextzugriff (PDF)

Excellent Survival and Long Term Outcomes in Infants Receiving Total Body Irradiation (TBI) for Conditioning Prior to Allogeneic Transplant

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.S169-S170

2024

Volltextzugriff (PDF)

ASFA's Response to 'Gender Inequities in Transfusion Medicine Society Recognition Awards'

Transfusion medicine reviews, 2023-01, Vol.37 (1), p.44-44

2023

Volltextzugriff (PDF)

Hematopoietic Stem Cell Transplantation in ARPC1B Deficiency

Journal of clinical immunology, 2022-10, Vol.42 (7), p.1535-1544

2022

Volltextzugriff (PDF)

Update to the ASFA guidelines on the use of therapeutic apheresis in ANCA‐associated vasculitis

Journal of clinical apheresis, 2020-09, Vol.35 (5), p.493-499

2020

Volltextzugriff (PDF)

Considerations for immune effector cell therapy collections: a white paper from the American Society for Apheresis

Cytotherapy (Oxford, England), 2022-09, Vol.24 (9), p.916-922

2022

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Englisch
(104)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(56)
Life Sciences & Biomedicine
(54)
Humans
(45)
Hematology
(29)
Female
(25)
Male
(24)
Child
(18)
Adolescent
(16)
Pediatrics
(16)
Hematology, Oncology And Palliative Medicine
(12)
Infant
(12)
Oncology
(12)
Biological And Medical Sciences
(11)
Medical Sciences
(11)
Apheresis
(10)
Middle Aged
(10)
Adult
(9)
Child, Preschool
(9)
Retrospective Studies
(9)
Hematopoietic Stem Cell Transplantation
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Extracorporeal photopheresis: cellular therapy for the treatment of acute and chronic graft-versus-host disease

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Late Effects in Pediatric High-risk Neuroblastoma Survivors After Intensive Induction Chemotherapy Followed by Myeloablative Consolidation Chemotherapy and Triple Autologous Stem Cell Transplants

Pre-transplant infusion of donor leukocytes treated with extracorporeal photochemotherapy induces immune hypo-responsiveness and long-term allograft survival in murine models

Non-pharmacologic strategies in hematopoietic stem cell transplantation

SP-19 - Update on extracorporeal photopheresis (ECP)

Update on extracorporeal photopheresis (ECP)

Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma

Clinical Significance of MYCN Amplification and Ploidy in Favorable-Stage Neuroblastoma: A Report From the Children's Oncology Group

The Impact of High-resolution HLA-A, HLA-B, HLA-C, and HLA-DRB1 on Transplant-related Outcomes in Single-unit Umbilical Cord Blood Transplantation in Pediatric Patients

American council on ECP (ACE): Why now?

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue

Betibeglogene Autotemcel Gene Therapy for Non–β0/β0 Genotype β-Thalassemia

Allogeneic hematopoetic stem cell transplantation in pediatric myelodysplastic syndromes: Improved outcomes for de novo disease

Extracorporeal photopheresis in pediatric patients: Practical and technical considerations

A Novel Mutation in WAS Gene Causing a Phenotypic Presentation of Wiskott-Aldrich Syndrome: A Case Report

Improvement in Iron Burden in Patients with Transfusion-Dependent β-Thalassemia (TDT) Treated with Betibeglogene Autotemcel (Beti-cel) Gene Therapy: Up to 9 Years of Follow-up

Sustained Efficacy, Safety, and Improved Quality of Life in Adult and Pediatric Patients with Transfusion-Dependent β-Thalassemia up to 9 Years Post Treatment with Betibeglogene Autotemcel (Beti-cel)

Reduced‐toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high‐risk hematologic malignancies

Excellent Survival and Long Term Outcomes in Infants Receiving Total Body Irradiation (TBI) for Conditioning Prior to Allogeneic Transplant

ASFA's Response to 'Gender Inequities in Transfusion Medicine Society Recognition Awards'

Hematopoietic Stem Cell Transplantation in ARPC1B Deficiency

Long Term Outcomes of 63 Patients with Transfusion-Dependent β-Thalassemia (TDT) Followed up to 7 Years Post-Treatment with betibeglogene autotemcel (beti-cel) Gene Therapy and Exploratory Analysis of Predictors of Successful Treatment Outcomes in Phase 3 Trials

Update to the ASFA guidelines on the use of therapeutic apheresis in ANCA‐associated vasculitis

Considerations for immune effector cell therapy collections: a white paper from the American Society for Apheresis

Suchergebnisse filtern